12.07.2023
MRX-503
An Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of Maralixibat in the Treatment of Subjects with Progressive Familial Intrahepatic Cholestasis (PFIC)
Show more12.07.2023
MRX-502
MRX-502: Randomized double-blind placebo-controlled Phase 3 study to evaluate the efficacy and safety of maralixibat in the treatment of subjects with Progressive Familial Intrahepatic Cholestasis (PFIC) – MARCH-PFIC
Show more12.07.2023
A4250-012 ASSERT
A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients with Alagille Syndrome (ASSERT)
Show more12.07.2023
A4250-011 BOLD
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Odevixibat (A4250) in Children with Biliary Atresia Who Have Undergone a Kasai Hepatoportoenterostomy (BOLD)
Show more